Literature DB >> 8454121

Medical students' attitudes toward pharmaceutical marketing: possibilities for change.

D C Vinson1, B McCandless, M C Hosokawa.   

Abstract

BACKGROUND: Concerns have been expressed about physicians' acceptance of gifts from pharmaceutical companies, but few studies have examined or attempted to change medical students' attitudes about accepting such gifts.
METHODS: We used a questionnaire survey to measure attitudes about accepting such gifts. We then carried out a field experiment to compare changes in second-year medical students' attitudes, seven weeks after a one-hour lecture and discussion about the appropriateness of pharmaceutical gifts, to changes in first-year students who were not exposed to the program.
RESULTS: Following the intervention, second-year students became less accepting of these marketing practices; first-year students showed no significant change. The difference between the groups after the intervention was statistically significant (P < .0001).
CONCLUSIONS: If medical students' attitudes about accepting gifts from pharmaceutical companies need to be changed, this study suggests that the process may be fostered with little investment of curricular time.

Keywords:  Empirical Approach; Health Care and Public Health; University of Missouri-Columbia

Mesh:

Year:  1993        PMID: 8454121

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  13 in total

1.  Norwegian medical students' attitudes towards the pharmaceutical industry.

Authors:  Dordi Lea; Olav Spigset; Lars Slørdal
Journal:  Eur J Clin Pharmacol       Date:  2010-03-19       Impact factor: 2.953

2.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

Review 3.  Interactions between pharmaceutical representatives and doctors in training. A thematic review.

Authors:  Daniella A Zipkin; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2005-08       Impact factor: 5.128

4.  Structured approach to pharmaceutical representatives. Family medicine residency program.

Authors:  S Kelcher; R Brownoff; L M Meadows
Journal:  Can Fam Physician       Date:  1998-05       Impact factor: 3.275

5.  Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.

Authors:  Amie C O'Donoghue; Vanessa Boudewyns; Kathryn J Aikin; Emily Geisen; Kevin R Betts; Brian G Southwell
Journal:  J Health Commun       Date:  2015-07-15

6.  Prescribers and pharmaceutical representatives: why are we still meeting?

Authors:  Melissa A Fischer; Mary Ellen Keough; Joann L Baril; Laura Saccoccio; Kathleen M Mazor; Elissa Ladd; Ann Von Worley; Jerry H Gurwitz
Journal:  J Gen Intern Med       Date:  2009-05-08       Impact factor: 5.128

Review 7.  Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.

Authors:  Kirsten E Austad; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2011-05-24       Impact factor: 11.069

Review 8.  Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis.

Authors:  Shahrzad Salmasi; Long Chiau Ming; Tahir Mehmood Khan
Journal:  J Pharm Policy Pract       Date:  2016-11-17

9.  Attitudes of medical students towards incentives offered by pharmaceutical companies -- perspective from a developing nation -- a cross-sectional study.

Authors:  Usman Tariq Siddiqui; Amarah Shakoor; Sarah Kiani; Farwa Ali; Maryam Sharif; Arun Kumar; Qasim Raza; Naseer Khan; Sardar Mohammed Alamzaib; Syed Farid-ul-Husnain
Journal:  BMC Med Ethics       Date:  2014-05-05       Impact factor: 2.652

10.  Questionable content of an industry-supported medical school lecture series: a case study.

Authors:  Navindra Persaud
Journal:  J Med Ethics       Date:  2013-06-11       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.